ArticlePublic health in practice (Oxford, England)2026
Adult adherence to multi-dose vaccine schedules: A population-based assessment of guideline concordance.
Article in Public health in practice (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Pneumococcal vaccination provides an accessible intervention to prevent pneumococcal infections. Approval of the 13-valent conjugate (PCV-13) with the existing 23-valent polysaccharide vaccine for adults resulted in cumbersome recommendations for 2-3 doses with complex spacing. Given these challenging logistics, we evaluated pneumococcal vaccination frequencies and guideline concordance. The objective was to determine concordance with pneumococcal vaccine guidelines among distinct at-risk groups and factors associated with and reasons for discordance. Study design: Retrospective, population-based cohort study. Methods: Records were reviewed for PCV-13 and/or PPSV-23 vaccination frequency and timing among vaccine-eligible adults aged ≥65 years (153,525 [57.1%]) and 19-64 years (115, 216 [42.9%]) with at least 2 clinic visits over 4 years. Underlying conditions, vaccine type and dates were systematically extracted from electronic health records (EHR) and statewide vaccine registry for a large academic health system in Colorado, covering the period 2014-2018. Descriptive statistics were used for vaccine frequency and guideline concordance. We determined the odds ratios for concordance among subgroups and multivariable logistic regression to identify factors associated with discordance. Results: Vaccine uptake was 69% among those ≥65 years and 27% for those aged 19-64 years. Chronic conditions were identified in 61% and immunocompromising conditions in 39% of persons 19-64 years of age. Vaccine recommendations were followed by 30.7% and 17.2% for those aged ≥65 years and 19-64 years respectively (p < 0.001). Guideline concordance was highest among persons living with HIV-1 infection (72.3%) (OR 8.03; 95% CI, 7.33-8.79 vs. overall cohort). Inclusion of statewide vaccine registry data increased ascertainment 22% (29,774 doses) over EHR alone. Limitations were potential missed vaccinations due to administrations outside the health-system which may not be reported to state vaccine registry. Conclusion: Concordance with complex national guidelines for pneumococcal vaccination was low in state-wide practices. Recent guidelines with simplified timing with one or two doses should improve these outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.